Drugs Made In America Acquisition Corp. DMAA
$10.80
$0.000.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.30K | 14.90K | 6.10K | 700.00 | 800.00 |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 48.90K | -- | 6.10K | 27.50K | 48.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 69.20K | 14.90K | 12.20K | 28.20K | 49.70K |
|
|
|||||
| Total Current Assets | 69.20K | 14.90K | 12.20K | 28.20K | 49.70K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 146.83M | 242.02M | 239.91M | 237.60M | 235.16M |
| Total Assets | 146.90M | 242.04M | 239.92M | 237.63M | 235.21M |
|
|
|||||
| Total Accounts Payable | 254.40K | 238.20K | 222.20K | 302.60K | 147.50K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 350.00K | 100.00K | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 2.34M | 154.00K | 154.00K | 154.00K | 154.00K |
| Total Other Current Liabilities | 2.34M | 154.00K | 154.00K | 154.00K | 154.00K |
| Total Current Liabilities | 2.94M | 492.20K | 376.20K | 456.60K | 301.40K |
|
|
|||||
| Total Current Liabilities | 2.94M | 492.20K | 376.20K | 456.60K | 301.40K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 350.00K | 100.00K | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 151.37M | 248.92M | 246.81M | 244.50M | 242.06M |
| Total Liabilities | 154.31M | 249.41M | 247.18M | 244.96M | 242.36M |
|
|
|||||
| Common Stock & APIC | 1.10K | 1.10K | 1.10K | 1.10K | 1.10K |
| Retained Earnings | -7.41M | -7.38M | -7.27M | -6.72M | -6.46M |
| Treasury Stock & Other | -- | -- | -- | -608.80K | -695.80K |
| Total Common Equity | -7.41M | -7.38M | -7.26M | -7.33M | -7.15M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.41M | -7.38M | -7.26M | -7.33M | -7.15M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.41M | -7.38M | -7.26M | -7.33M | -7.15M |
|
|
|||||